PlainRecalls
FDA Drug Low Class III Terminated

Metoprolol Tartrate Injection, USP, 5 mg/ 5 mL (1 mg/mL), 5 mL per sterile single use glass vial, Rx Only, Manufactured for: Claris Lifesciences, Inc., North Brunswick, NJ 08902. By: Claris Injectables Ltd., Gujarat, India. NDC: 36000-033-10

Reported: November 14, 2018 Initiated: October 15, 2018 #D-0222-2019

Product Description

Metoprolol Tartrate Injection, USP, 5 mg/ 5 mL (1 mg/mL), 5 mL per sterile single use glass vial, Rx Only, Manufactured for: Claris Lifesciences, Inc., North Brunswick, NJ 08902. By: Claris Injectables Ltd., Gujarat, India. NDC: 36000-033-10

Reason for Recall

Failed pH Specifications: Upward shift in the pH of the solution within the shelf life of the impacted lots.

Details

Units Affected
402,165 vials
Distribution
Distributed nationwide in the USA and Puerto Rico
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
Metoprolol Tartrate Injection, USP, 5 mg/ 5 mL (1 mg/mL), 5 mL per sterile single use glass vial, Rx Only, Manufactured for: Claris Lifesciences, Inc., North Brunswick, NJ 08902. By: Claris Injectables Ltd., Gujarat, India. NDC: 36000-033-10. Recalled by Baxter Healthcare Corporation. Units affected: 402,165 vials.
Why was this product recalled?
Failed pH Specifications: Upward shift in the pH of the solution within the shelf life of the impacted lots.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 14, 2018. Severity: Low. Recall number: D-0222-2019.